Dr. Eric Genden on Prominent Head and Neck Cancers
February 21, 2013
Mount Sinai's Dr. Eric Genden discusses the most common head and neck cancers and the worldwide epidemic of thyroid cancer and HPV-associated throat cancer. Dr. Genden is Chairman of the Department of Otolaryngology and Associate Professor of Otolaryngology-Head and Neck Surgery, and Immunobiology. As Chief of the Division of Head and Neck Oncology, Dr. Genden is board certified in head and neck surgery and fellowship trained in head and neck oncology and microvascular reconstruction. His practice is centered on thyroid, parathyroid surgery, head and neck cancer surgery, and airway reconstruction. Dr. Genden is nationally recognized as a leader in head and neck cancer surgery and head and neck microvascular reconstruction.
About TransOral Robotic Surgery (TORS)
April 12, 2012
Mount Sinai is one of the few centers in the world using a robotic approach instead of open surgery to remove tumors at the back of the throat and base of the tongue. This technology has changed the lives of our patients.
Dr. Satish Govindaraj Discusses Testing for Sinusitis
February 20, 2013
His current research is focused on the impact of mucosal immunity in chronic sinusitis and quality of life after endoscopic skull base procedures.
Clinical Trial for Tonsil and Tongue Base Cancer
July 9, 2014
Researchers at Mount Sinai are now conducting a therapeutic clinical trial testing a novel vaccine (ADXS11-001) for patients with HPV-related oropharyngeal (tonsil and tongue base) cancer who are eligible to undergo robot-assisted surgery. Learn more about the Tisch Cancer Institute